Sign In
Buy BCEL
$0.0900
+0 (+0%)
At Close: Sep 13, 2024
Restaurant Owners Offer Reality Check To Trump As President Touts Progress Made Toward Reopening
11:06am, Tuesday, 19'th May 2020
During a meeting with restaurant owners, President Donald Trump was in a notably good mood. “It almost feels like today is the first day,” Trump said at another point in the meeting. “Last week
Changes proposed to labour laws are unconstitutional
04:52am, Tuesday, 19'th May 2020
Rather than encouraging workers to return by securing wages and improving working conditions, the amendments introduced by the states are removing basic labour law protections.
Activists: Senate Should Pass Paycheck Protection Program Improvements
01:40am, Sunday, 17'th May 2020
The Paycheck Protection Program as structured does not help the tens of thousands of restaurants who are still prohibited
Atreca Reports First Quarter 2020 Financial Results and Recent Corporate Developments
08:30pm, Thursday, 14'th May 2020
SOUTH SAN FRANCISCO, Calif., May 14, 2020 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated.
Coronavirus cases among refugees on Lesbos spark fresh calls for evacuation
01:51pm, Thursday, 14'th May 2020
NGOs say cases found among arriving refugees show urgent need to move more migrants from Moria camp to mainland
Atreca Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
09:00pm, Wednesday, 13'th May 2020
SOUTH SAN FRANCISCO, Calif., May 13, 2020 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated.
BMS & bluebird bio to Present Updated Positive Results from Pivotal KarMMa Study of Ide-cel in Relapsed and Refractory Multiple Myeloma Patients
Atreca Announces Participation in the 2020 RBC Capital Markets Virtual Global Healthcare Conference
08:30pm, Tuesday, 12'th May 2020
SOUTH SAN FRANCISCO, Calif., May 12, 2020 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique.
Four World-Famous Chefs on Where Destination Dining Will Go
12:38pm, Tuesday, 12'th May 2020
These elite chefs consider a bleak future: a roundtable discussion with Noma’s René Redzepi, Blue Hill’s Dan Barber, Kith/Kin’s Kwame Onwuachi and Sqirl’s Jessica Koslow
Royal heartbreak: Charles' desperate message amid coronavirus horror
12:48pm, Monday, 11'th May 2020
PRINCE CHARLES issued a "desperate" message to those working on the frontline in war-torn countries across the globe at a time when the coronavirus pandemic is deepening.
Asylum seekers who worked pre-pandemic not eligible for Covid-19 support
12:23am, Friday, 08'th May 2020
Asylum seekers who temporarily received €350 per week have been put back on €38.80 weekly stipend
bluebird bio, Inc. (Nasdaq: BLUE) announced today that updated results from the pivotal Phase 2 KarMMa study evaluating the efficacy and safety of ide
Yarl's Wood immigration removal centre held pandemic exercise in January
02:30pm, Thursday, 07'th May 2020
Operation prompts questions about how much government knew about forecast scale of Covid-19 outbreak
Op-Ed: Local bars and restaurants face extinction because of coronavirus – and government needs to step up
05:05pm, Monday, 04'th May 2020
Independent bars and restaurants found some relief in the Paycheck Protection Program, which offers low interest, short-term loans with the potential of forgiveness. That is not nearly enough, writes
Bank of New York Mellon Corp Raises Stock Position in Atreca (NASDAQ:BCEL)
09:18am, Friday, 01'st May 2020
Bank of New York Mellon Corp boosted its holdings in Atreca (NASDAQ:BCEL) by 64.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 19,294 shares of the company’s sto
